Jinyu Bio-Tech announces share repurchase progress

Jinyu Bio-Tech (SSE:600201) announced the progress of its share repurchase program, revealing that the company has repurchased 1,538.33 million shares, representing 1.3731% of the total share capital, through centralized bidding as of June 30, 2025. The repurchase price ranged from CNY 6.37 to CNY 7.30 per share, with a total expenditure of CNY 10,555.22 million, excluding commissions and other transaction costs. This buyback initiative, approved on October 30, 2024, aims to implement employee stock ownership plans or equity incentives, and safeguard company value and shareholder interests. The company will continue to make repurchase decisions based on market conditions and fulfill information disclosure obligations as required by regulations. The board reminds investors to pay attention to investment risks.